Morning Market Movers By: Benzinga via Benzinga December 09, 2014 at 09:40 AM EST bluebird bio (NASDAQ: BLUE) shares climbed 57.50% to $77.00 following an announcement of positive data for its LentiGlobin BB305 drug. ... Read More >> Related Stocks: Aptose Bioscns AutoZone Bluebird Bio Burlington Stores Inc Mazor Robotics Ads Pdc Energy Inc